An interventional study of Laser therapy and Negative pressure therapy is applied to the negative pressure group in Neuropathic Ulcers, sponsored by Cairo University. Not yet recruiting at 1 site in Egypt. Open to participants aged 40 Years to 60 Years. Per ClinicalTrials.gov, last updated 2026-11-05.
Sponsored by Cairo University · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 22 studies in Ulcer with a site in Egypt — 3 open to participants now, 3 under way, 1 of them phase 3. Ulcer · Egypt.
Among the 22 studies in Ulcer with a site in Egypt, this one is the 5th largest by planned enrollment of the 20 interventional ones that give a count, is one of 2 that started in 2026, is one of 14 with no phase, and was the 21st registered.
360 studies on the registry are indexed under Ulcer; 61 are open to participants now.
Browse Ulcer studies →3 of the 22 studies in Ulcer with a site in Egypt are open now. Recruiting first, the newest first:
British University In Egypt · Sites in Egypt
Mansoura University · Sites in Egypt
Ages 18–80 · Healthy volunteers
A study can be open while its sites in Egypt have not opened yet or have stopped. Only those recruiting at a site in Egypt →
Of the 39 Ulcer studies recruiting now, 30 (77%) set no upper age limit and 3 (8%) stop at 75 or younger; 3 take children under 18; 5 take healthy volunteers.
This study: 40 Years to 60 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
22 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 2 3 · Phase 3 3 · Phase 4 1
First in 2012; this study’s year is marked. 2 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 70 is close to the median of 65 across 292 interventional studies indexed under Ulcer.
Median enrollment 38 across the 20 interventional studies, 72 across the 2 observational. Of the 14 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
2 of 22 have an industry lead sponsor. The 10 most frequent:
Cairo University is the lead sponsor of 4,967 studies on the registry; 1,474 are open to participants now.
Of its 37 completed or terminated interventional studies of FDA-regulated products, 5 (14%) have results posted.
Cairo University has 6 studies filed under Ulcer — fewer than ten, so there is no comparison to draw.
2 of the studies in Ulcer with a site in Egypt that are under way reach primary completion within a year, 1 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06910579Phase 3British University In EgyptOxygenated Gel Therapy in the Management of Oral Aphthous Ulcers | 2027-01-30 |
| NCT07557524Cairo UniversityPulsed High Intensity Laser Versus Negative Pressure Therapy On Neuropathic Ulcers | 2027-02-28 |
Add all 2 to your calendar (.ics) → With an account.
Among the 22 studies in Ulcer with a site in Egypt, from their registry updates:
This tab as a report to print or save as PDF → With an account.
the study comparess between laser therapy and vac to decide which on is superior
the vac will be used for 4 weeks the laser will be used for 3 session per weak for four weaks
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
-
The subject selection will be according to the following criteria:
Exclusion Criteria:
The potential participants will be excluded if they meet one of the following criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.
Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.
Cancer (malignancy)
Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.
Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
In this group of the study, will receive pulsed High intensity laser therapy (GaAs laser) in addition to traditional wound management for 3 sessions per week for four weeks at 980 nm laser irradiation at 15 W at 20hz laser emission potently stimulates defens in production in keratinocytes via ROS-mediated pathways. While these in vitro parameters highlight mechanistic efficacy, clinical translation for chronic wounds requires: Non-contact scanning techniques
Device: Laser therapy
In this group of the study, will receive negative pressure wound therapy in addition to traditional wound management for four weeks.
Device: Negative pressure therapy is applied to the negative pressure group
Pulsed high intensity laser therapy is applied to wound bed
It will be applied to patients with chronic wound
wound surface area
imitoMeasure Mobil application: The ImitoMeasure app is a noncontact digital planimetry application that measures wound surface area and offers an advantage over other methods. The introduction of smartphones with high-definition cameras. These devices are not only portable and inexpensive, but they also provide the convenience of on-the-spot assessments.
Time frame: one month
qulity of life
Wound quality of life questionnaire The Wound-QoL questionnaire has been tested in a previous study, indicating that it is a reliable and valid tool for assessing HRQoL in chronic wounds. It contains 17 items, each with a 5-point Likert scale (0 = not at all, 4 = very much).
Time frame: one month and three months
Plan to share: Undecided
Start is estimated for Nov 2026; primary completion for Feb 2027, 3 months later.
Of 44 non-industry interventional studies with no phase under Ulcer, half reached primary completion within 25 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 64. This study's planned 3 months is below that.
Counting every sponsor, half of 69 studies reached it within 25 months; a quarter within 10 and three quarters within 43.
Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 5, 2026: start Apr 2026 → Nov 2026, primary completion Sep 2026 → Feb 2027 and completion Sep 2026 → Feb 2027.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.